Diffusion Pharmaceuticals Inc

(NASDAQ:DFFN)

Latest On Diffusion Pharmaceuticals Inc (DFFN):

Date/Time Type Description Signal Details
2023-03-31 03:39 ESTNewsDiffusion to merge with EIP Pharma in all-stock dealN/A
2022-11-15 17:47 ESTNewsDiffusion Pharmaceuticals GAAP EPS of -$1.37 beats by $0.69N/A
2022-10-25 10:06 ESTNewsDiffusion to undertake strategic review, options may include company saleN/A
2022-08-16 23:47 ESTNewsDiffusion raised to Buy at H.C. Wainwright after Q2 update on lead assetN/A
2022-08-12 17:49 ESTNewsDiffusion Pharmaceuticals GAAP EPS of -$2.06 misses by $0.02N/A
2022-05-13 10:49 ESTNewsDiffusion Pharmaceuticals GAAP EPS of -$2.22N/A
2022-04-18 14:12 ESTNewsDiffusion Pharma crashes after announcing reverse stock splitN/A
2022-03-21 11:35 ESTNewsDiffusion Pharmaceuticals GAAP EPS of -$0.25N/A
2021-11-22 22:37 ESTNewsDosing underway in Diffusion Pharma's Altitude trialN/A
2021-11-11 04:34 ESTNewsDiffusion Pharmaceuticals EPS misses by $0.08N/A
2021-08-30 10:40 ESTNewsDiffusion Pharma gains 6% on FDA clearance of IND for TSC in lung diseaseN/A
2021-08-11 19:18 ESTNewsDiffusion Pharmaceuticals reports Q2 resultsN/A
2021-08-11 19:17 ESTNewsDiffusion provides COVID-19 study data timeline update, sees cash runway through 2023N/A
2021-07-21 03:58 ESTNewsDiffusion Pharmaceuticals posts positive trend in oxygenation from TCOM trialN/A
2021-03-25 12:19 ESTNewsDiffusion Pharmaceuticals completes enrollment and dosing in Phase 1 TCOM studyN/A
2021-03-19 04:47 ESTFinancialsCompany financials have been released.Neutral
2021-03-18 17:25 ESTNewsDiffusion pharmaceuticals starts dosing in TCOM studyN/A
2021-03-18 12:30 ESTEarnings EstimateAn EPS average of -$0.20 is estimated for the 2022 year.Sell
2021-03-17 21:31 ESTNewsDiffusion Pharmaceuticals reports FY resultsN/A
2021-03-14 13:15 ESTNewsDiffusion Pharmaceutical (DFFN) Presents At HC Wainwright Global Life Sciences ConferenceN/A
2021-02-17 19:46 ESTNewsDiffusion Pharmaceuticals closes $30M bought deal offeringN/A
2021-02-17 02:13 ESTNewsDiffusion Pharma completes early-stage study of TSC in COVID-19, shares up 18%N/A
2021-02-12 17:15 ESTNewsDiffusion Pharma plummets 18% on capital raiseN/A
2021-02-11 23:41 ESTNewsDiffusion Pharmaceuticals stock slumps 11% as company raises $10M capitalN/A
2020-11-26 19:44 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 07:41 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 03:45 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 11:45 ESTEarnings EstimateAn EPS average of -$0.06 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-12 21:25 ESTNewsDiffusion Pharmaceuticals EPS misses by $0.01N/A
2020-11-07 15:36 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 12:32 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:40 ESTFinancialsCompany financials have been released.Neutral
2020-09-10 22:32 ESTNewsDosing is underway for Diffusion Pharma's lead asset in early-stage COVID-19 studyN/A
2020-09-09 17:26 ESTNewsDiffusion Pharma names new CEON/A
2020-08-25 08:38 ESTAnalyst RatingThe Analyst Target Price has decreased from $3.5 to $2.75.Neutral
2020-08-14 08:34 ESTFinancialsCompany financials have been released.Neutral
2020-08-10 10:35 ESTNewsDiffusion Pharmaceuticals EPS misses by $0.04N/A
2020-08-09 00:33 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 00:46 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 20:02 ESTNewsDiffusion Pharma changes design of early-stage study of TSC in COVID-19N/A
2020-07-23 16:48 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 08:30 ESTFinancialsCompany financials have been released.Neutral
2020-07-08 08:12 ESTNewsDiffusion Pharma files IND to launch COVID-19 program with trans sodium crocetinateN/A
2020-07-08 08:11 ESTNewsDiffusion Pharma to launch study of trans sodium crocetinate in COVID-19N/A
2020-07-01 08:33 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 12:40 ESTNewsDiffusion Pharma to initiate early-stage TSC study in COVID-19 patients in EuropeN/A
2020-06-12 04:31 ESTFinancialsCompany financials have been released.Neutral
2020-06-02 14:05 ESTNewsDiffusion Pharmaceuticals regains Nasdaq complianceN/A
2020-06-02 08:30 ESTEarnings EstimateAn EPS average of -$0.06 is estimated for the quarter ending on September 30, 2020.Buy
2020-05-27 04:34 ESTFinancialsCompany financials have been released.Neutral

About Diffusion Pharmaceuticals Inc (DFFN):

Diffusion Pharmaceuticals Inc., a clinical stage biotechnology company, develops treatments for life-threatening medical conditions. Its lead product candidate is transcrocetinate sodium, which is in Phase III trials for the treatment of glioblastoma multiforme (GBM); Phase II clinical trials for the treatment of metastatic brain cancer; and Phase II trial for the treatment of acute stroke. The company is also developing RES-529, a PI3K/Akt/mTOR pathway inhibitor, which has completed two Phase I clinical trials for the treatment of age-related macular degeneration; and is in pre-clinical development stage for the treatment of oncology primarily GBM. Diffusion Pharmaceuticals Inc. has a cooperative research agreement with the University of Virginia Health and the Integrated Translational Research Institute of Virginia to evaluate the transcrocetinate sodium in patients with acute respiratory distress syndrome associated with COVID-19 infection. The company was founded in 2001 and is headquartered in Charlottesville, Virginia.

DFFN Quotes by TradingView

See Advanced Chart

General

  • Name Diffusion Pharmaceuticals Inc
  • Symbol DFFN
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 10
  • Last Split Factor1:15
  • Last Split Date2018-12-14
  • Fiscal Year EndDecember
  • IPO Date2016-01-04
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.diffusionpharma.com
View More

Valuation

  • Trailing PE 70
  • Price/Book (Most Recent Quarter) 3.83
  • Enterprise Value EBITDA 0.01
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Current Year EPS Estimate -$0.19
  • Next Year EPS Estimate -$0.20
  • Next Quarter EPS Estimate -$0.05
  • Return on Assets -39%
  • Return on Equity -63%
  • Earnings Per Share -$4.97
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 109.04 million
  • EBITDA -11031373
  • Analyst Target Price $2.75
  • Book Value Per Share $0.39
View More

Share Statistics

  • Shares Outstanding 101.9 million
  • Shares Float 101.72 million
  • % Held by Insiders 21%
  • % Held by Institutions 10.71%
  • Shares Short 1.82 million
  • Shares Short Prior Month 517864
  • Short Ratio 0.12
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 1.72
  • 52 Week High $1.85
  • 52 Week Low $0.28
  • 50 Day Moving Average 1.17
  • 200 Day Moving Average 0.93
View More

Dividends

  • Dividend Date 2018-12-14
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Diffusion Pharmaceuticals Inc (DFFN) Dividend Calendar:

DFFN's last dividend payment was made to shareholders on December 14, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Diffusion Pharmaceuticals Inc (DFFN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$N/A-$0.06-$0.05-20%
2020-09-302020-11-12$N/A-$0.07-$0.06-27.27%
2020-06-302020-08-07$N/A-$0.10-$0.06-81.82%
2020-03-312020-05-11$N/A-$0.07-$0.0917.65%
2019-12-312020-03-17$N/A-$0.11-$0.1315.38%
2019-09-302019-11-08$N/A-$0.60-$0.7115.49%
2019-06-302019-08-08$N/A-$0.63-$0.9030%
2019-03-312019-05-09$N/A-$0.81-$0.9110.5%
2018-12-312019-03-19$N/A-$1.49-$0.90-65.56%
2018-09-302018-11-13$N/A-$1.95-$0.90-116.67%
2018-06-302018-08-10$N/A-$0.75-$0.9016.67%
2018-03-312018-05-10$N/A-$4.05-$0.83-390.91%
2017-12-312018-03-29$N/A-$1.65-$0.60-175%
2017-09-302017-11-13$N/A$3.00-$6.45146.51%
2017-06-302017-08-14$N/A$13.20-$5.55337.84%
2017-03-312017-05-15$N/A-$41.70-$4.80-768.75%
2016-12-312017-03-31$N/A-$3.60-$5.1029.41%
2016-09-302016-11-14$N/A-$7.95-$5.10-55.88%
2016-06-302016-08-15$N/A-$6.00-$4.50-33.33%
2016-03-312016-05-16$N/A-$9.34
2015-12-312016-03-25$N/A-$25.50-$42.0039.29%
2015-09-302015-11-12$N/A-$106.56
2015-06-302015-08-12$N/A-$2.10-$1.80-16.67%
2015-03-312015-04-03$N/A-$1.90-$1.70-11.76%
2014-12-312015-02-25$N/A-$40.84
2014-09-302014-11-12$N/A-$27.71
2014-06-302014-08-14$N/A-$51.93
2014-03-312014-03-31$N/A-$34.89
2013-12-312013-12-31-$20.89
2013-09-302013-09-30$N/A-$55.21
2013-06-302013-06-30$N/A$120.54
2013-03-312013-03-31-$437.13
2012-12-312012-12-31$331.84
2012-09-302012-09-30$N/A-$579.01
2012-06-302012-06-30-$574.00
2012-03-312012-03-31-$421.74
2011-12-312011-12-31-$1,512.45
2011-09-302011-09-30$N/A-$838.80
2011-03-312011-03-31-$400.41
2010-12-312010-12-31-$190.12
2010-09-302010-09-30-$439.68
2009-12-312009-12-31-$447.76
2009-09-302009-09-30-$155.32
2009-06-302009-06-30-$163.82
2009-03-312009-03-31-$107.00
2008-12-312008-12-31-$435.24
2008-09-302008-09-30-$73.19
2008-06-302008-06-30-$78.04
2008-03-312008-03-31$19.69
2007-09-302007-09-30-$1,614.35
2007-06-302007-06-30-$5,411.62
2007-03-312007-03-31-$665.03
2000-09-302000-09-30-$1,000,000.00
2000-06-302000-06-30-$741,485.61
2000-03-312000-03-31-$513,519.81
1999-03-311999-03-31-$58,286.94
1998-12-311998-12-31-$89,542.36
1998-09-301998-09-30$75,258.19

Diffusion Pharmaceuticals Inc (DFFN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Diffusion Pharmaceuticals Inc (DFFN) Chart:

Diffusion Pharmaceuticals Inc (DFFN) News:

Below you will find a list of latest news for Diffusion Pharmaceuticals Inc (DFFN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Diffusion Pharmaceuticals Inc (DFFN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest DFFN Trades:

Date Shares Price
Jun 13, 2022 5:46 PM EST100$7.52
Jun 13, 2022 5:46 PM EST100$7.54
Jun 13, 2022 6:51 PM EST100$7.53
Jun 13, 2022 7:44 PM EST2$7.4
Jun 13, 2022 7:59 PM EST100$7.72

Diffusion Pharmaceuticals Inc (DFFN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920013423/0001437749-20-013423-index.htm
2018-02-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1053691/000000000018004839/0000000000-18-004839-index.htm
2019-05-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1053691/000000000019008805/0000000000-19-008805-index.htm
2019-09-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1053691/000000000019013592/0000000000-19-013592-index.htm
2019-10-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1053691/000000000019014765/0000000000-19-014765-index.htm
2019-12-23UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1053691/000000000019016775/0000000000-19-016775-index.htm
2020-06-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1053691/000000000020004919/0000000000-20-004919-index.htm
2020-09-29UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1053691/000000000020009153/0000000000-20-009153-index.htm
2019-06-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1053691/000091957419003945/0000919574-19-003945-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1053691/000091957420001439/0000919574-20-001439-index.htm
2018-01-29SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1053691/000119312518023271/0001193125-18-023271-index.htm
2019-06-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1053691/000119312519163505/0001193125-19-163505-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1053691/000119312520038074/0001193125-20-038074-index.htm
2019-11-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1053691/000121390019024508/0001213900-19-024508-index.htm
2019-12-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1053691/000121390019026687/0001213900-19-026687-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774918000258/0001437749-18-000258-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774918000259/0001437749-18-000259-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774918000260/0001437749-18-000260-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774918000261/0001437749-18-000261-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774918000263/0001437749-18-000263-index.htm
2018-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774918000264/0001437749-18-000264-index.htm
2018-01-16S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1053691/000143774918000686/0001437749-18-000686-index.htm
2018-01-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1053691/000143774918000700/0001437749-18-000700-index.htm
2018-01-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1053691/000143774918000721/0001437749-18-000721-index.htm
2018-01-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774918000800/0001437749-18-000800-index.htm
2018-01-19424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1053691/000143774918000841/0001437749-18-000841-index.htm
2018-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774918000941/0001437749-18-000941-index.htm
2018-02-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1053691/000143774918001767/0001437749-18-001767-index.htm
2018-02-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1053691/000143774918002214/0001437749-18-002214-index.htm
2018-02-14424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1053691/000143774918002562/0001437749-18-002562-index.htm
2018-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774918003914/0001437749-18-003914-index.htm
2018-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774918004965/0001437749-18-004965-index.htm
2018-04-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1053691/000143774918006050/0001437749-18-006050-index.htm
2018-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774918006155/0001437749-18-006155-index.htm
2018-04-20PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1053691/000143774918007347/0001437749-18-007347-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1053691/000143774918008132/0001437749-18-008132-index.htm
2018-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1053691/000143774918008133/0001437749-18-008133-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1053691/000143774918009433/0001437749-18-009433-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774918009449/0001437749-18-009449-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774918011908/0001437749-18-011908-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774918012012/0001437749-18-012012-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774918012013/0001437749-18-012013-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774918012014/0001437749-18-012014-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774918012015/0001437749-18-012015-index.htm
2018-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1053691/000143774918015223/0001437749-18-015223-index.htm
2018-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1053691/000143774918015228/0001437749-18-015228-index.htm
2018-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774918015601/0001437749-18-015601-index.htm
2018-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774918016475/0001437749-18-016475-index.htm
2018-09-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774918017551/0001437749-18-017551-index.htm
2018-10-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774918017902/0001437749-18-017902-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1053691/000143774918020566/0001437749-18-020566-index.htm
2018-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774918020812/0001437749-18-020812-index.htm
2018-12-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774918021995/0001437749-18-021995-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774919000343/0001437749-19-000343-index.htm
2019-01-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774919001064/0001437749-19-001064-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774919001522/0001437749-19-001522-index.htm
2019-03-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1053691/000143774919005256/0001437749-19-005256-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1053691/000143774919008328/0001437749-19-008328-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1053691/000143774919008329/0001437749-19-008329-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1053691/000143774919009285/0001437749-19-009285-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774919009288/0001437749-19-009288-index.htm
2019-05-16S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1053691/000143774919010251/0001437749-19-010251-index.htm
2019-05-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1053691/000143774919010685/0001437749-19-010685-index.htm
2019-05-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1053691/000143774919010847/0001437749-19-010847-index.htm
2019-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774919010905/0001437749-19-010905-index.htm
2019-06-03DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774919011280/0001437749-19-011280-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774919011940/0001437749-19-011940-index.htm
2019-07-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774919014277/0001437749-19-014277-index.htm
2019-07-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774919014278/0001437749-19-014278-index.htm
2019-07-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774919014279/0001437749-19-014279-index.htm
2019-08-064/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774919015539/0001437749-19-015539-index.htm
2019-08-064/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774919015540/0001437749-19-015540-index.htm
2019-08-064/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774919015541/0001437749-19-015541-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1053691/000143774919016051/0001437749-19-016051-index.htm
2019-08-20S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1053691/000143774919017198/0001437749-19-017198-index.htm
2019-09-09S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1053691/000143774919018077/0001437749-19-018077-index.htm
2019-09-26CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1053691/000143774919019093/0001437749-19-019093-index.htm
2019-09-27S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1053691/000143774919019129/0001437749-19-019129-index.htm
2019-10-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1053691/000143774919019717/0001437749-19-019717-index.htm
2019-10-10424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1053691/000143774919019919/0001437749-19-019919-index.htm
2019-10-16S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1053691/000143774919020133/0001437749-19-020133-index.htm
2019-10-28S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1053691/000143774919020753/0001437749-19-020753-index.htm
2019-10-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1053691/000143774919020757/0001437749-19-020757-index.htm
2019-10-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1053691/000143774919020758/0001437749-19-020758-index.htm
2019-10-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1053691/000143774919020944/0001437749-19-020944-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1053691/000143774919022149/0001437749-19-022149-index.htm
2019-11-08S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1053691/000143774919022192/0001437749-19-022192-index.htm
2019-11-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1053691/000143774919022194/0001437749-19-022194-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774919022309/0001437749-19-022309-index.htm
2019-11-13S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1053691/000143774919022543/0001437749-19-022543-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774919022699/0001437749-19-022699-index.htm
2019-11-15424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1053691/000143774919022972/0001437749-19-022972-index.htm
2019-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774919023055/0001437749-19-023055-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774919023215/0001437749-19-023215-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774919024112/0001437749-19-024112-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774919024137/0001437749-19-024137-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774919024211/0001437749-19-024211-index.htm
2019-12-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1053691/000143774919024368/0001437749-19-024368-index.htm
2019-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774919024424/0001437749-19-024424-index.htm
2019-12-17DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774919024544/0001437749-19-024544-index.htm
2019-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774919024718/0001437749-19-024718-index.htm
2019-12-20S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1053691/000143774919024737/0001437749-19-024737-index.htm
2019-12-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1053691/000143774919024829/0001437749-19-024829-index.htm
2019-12-30424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1053691/000143774919024983/0001437749-19-024983-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920000403/0001437749-20-000403-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920000523/0001437749-20-000523-index.htm
2020-01-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920000548/0001437749-20-000548-index.htm
2020-01-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920000552/0001437749-20-000552-index.htm
2020-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920001420/0001437749-20-001420-index.htm
2020-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920001421/0001437749-20-001421-index.htm
2020-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920001423/0001437749-20-001423-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920001905/0001437749-20-001905-index.htm
2020-03-1710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1053691/000143774920005469/0001437749-20-005469-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920005589/0001437749-20-005589-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920006025/0001437749-20-006025-index.htm
2020-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920006773/0001437749-20-006773-index.htm
2020-04-17PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920007972/0001437749-20-007972-index.htm
2020-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920008768/0001437749-20-008768-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920008837/0001437749-20-008837-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1053691/000143774920008838/0001437749-20-008838-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920009524/0001437749-20-009524-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920010091/0001437749-20-010091-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1053691/000143774920010278/0001437749-20-010278-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920010323/0001437749-20-010323-index.htm
2020-05-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920010606/0001437749-20-010606-index.htm
2020-05-15DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920011014/0001437749-20-011014-index.htm
2020-05-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1053691/000143774920011311/0001437749-20-011311-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920011442/0001437749-20-011442-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920011445/0001437749-20-011445-index.htm
2020-05-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920011747/0001437749-20-011747-index.htm
2020-05-27DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920011845/0001437749-20-011845-index.htm
2020-05-29S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1053691/000143774920012079/0001437749-20-012079-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920012220/0001437749-20-012220-index.htm
2020-06-03S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1053691/000143774920012354/0001437749-20-012354-index.htm
2020-06-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1053691/000143774920012357/0001437749-20-012357-index.htm
2020-06-08424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1053691/000143774920012632/0001437749-20-012632-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920013000/0001437749-20-013000-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920013327/0001437749-20-013327-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920013420/0001437749-20-013420-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920013421/0001437749-20-013421-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920013422/0001437749-20-013422-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920013423/0001437749-20-013423-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920014790/0001437749-20-014790-index.htm
2020-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920015912/0001437749-20-015912-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1053691/000143774920017080/0001437749-20-017080-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920017366/0001437749-20-017366-index.htm
2020-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920019346/0001437749-20-019346-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920019460/0001437749-20-019460-index.htm
2020-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920019576/0001437749-20-019576-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920019648/0001437749-20-019648-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920019730/0001437749-20-019730-index.htm
2020-09-25S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1053691/000143774920020243/0001437749-20-020243-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920020264/0001437749-20-020264-index.htm
2020-09-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1053691/000143774920020475/0001437749-20-020475-index.htm
2020-10-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920020634/0001437749-20-020634-index.htm
2020-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920020635/0001437749-20-020635-index.htm
2020-10-02424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/1053691/000143774920020672/0001437749-20-020672-index.htm
2020-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920020986/0001437749-20-020986-index.htm
2020-10-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920021142/0001437749-20-021142-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920021143/0001437749-20-021143-index.htm
2020-10-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1053691/000143774920021340/0001437749-20-021340-index.htm
2020-10-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920021434/0001437749-20-021434-index.htm
2020-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1053691/000143774920021435/0001437749-20-021435-index.htm
2019-05-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1053691/000153561019000088/0001535610-19-000088-index.htm
2020-01-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1053691/000153561020000025/0001535610-20-000025-index.htm
2018-01-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1053691/999999999518000143/9999999995-18-000143-index.htm
2018-02-13EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1053691/999999999518000437/9999999995-18-000437-index.htm
2019-05-22EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1053691/999999999519001185/9999999995-19-001185-index.htm
2019-10-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1053691/999999999519002273/9999999995-19-002273-index.htm
2019-11-13EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1053691/999999999519002563/9999999995-19-002563-index.htm
2019-12-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1053691/999999999519002944/9999999995-19-002944-index.htm
2020-06-05EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1053691/999999999520001389/9999999995-20-001389-index.htm
2020-10-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1053691/999999999520002734/9999999995-20-002734-index.htm